AU Stock MarketDetailed Quotes
SNT Syntara Ltd
- 0.044
- +0.009+25.71%
20min DelayMarket Closed Jul 12 16:00 AET
52.54MMarket Cap-2588P/E (Static)
0.044High0.036Low4.66MVolume0.036Open0.035Pre Close183.80KTurnover0.04452wk High0.80%Turnover Ratio1.19BShares0.01452wk Low-0.017EPS TTM25.52MFloat Cap0.044Historical HighLossP/E (Static)579.94MShs Float0.014Historical Low-0.017EPS LYR22.86%Amplitude--Dividend TTM8.80P/B1Lot Size--Div YieldTTM
About Syntara Ltd Company
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis.
Company Profile
SymbolSNT
Company NameSyntara Ltd
Founded1998
MarketASX
Employees69
Fiscal Year Ends06-30
Address20 Rodborough Road Locked Bag 5015
CitySydney
CountryAustralia
Zip Code2086
Phone+61 294547200
Websitehttps://www.syntaratx.com.au
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- Gary Phillips
- Chief Executive Officer
- --
- David McGarvey
- Chief Financial Officer and Company Secretary
- --
- Jana Baskar
- Chief Medical Officer
- --
- Kathleen Mary Metters
- Non-Executive Chairman
- --
- Simon Green
- Director
- --
- Hashan De Silva
- Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg